- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01702220
Calmer Life: Testing the Effectiveness of a Treatment for Anxiety
Calmer Life: A Randomized Controlled Trial of a Participant-Centered Treatment for Anxiety in Low-Income, Older Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cognitive behavioral treatment (CBT) produces positive outcomes for late-life worry/GAD in academic and primary care settings, but minorities are significantly underrepresented in clinical trials, and standard CBT poorly addresses the needs of low-income minority older adults in underserved communities. More attention needs to be given to service delivery of anxiety treatments for underserved older adults. Calmer Life (CL) is a culturally tailored, participant-centered research study that offers a skills-based intervention for late-life anxiety and includes other elements of care to meet the needs of underserved, minority older adults, including the option to integrate religion/spirituality (R/S), flexible delivery modes, and modular treatment format.
Participants will be randomly assigned to CL or Enhanced Community Care(ECC). CL and ECC will be provided by behavioral health clinicians recruited from partner organizations, psychology trainees, and other research staff over 3 months. Assessments will occur at baseline and 3 months.
Participants in the CL condition can choose up to 12 individual skill sessions, and will be recommended to complete a minimum of 6 sessions. If participants desire to incorporate R/S, an R/S assessment occurs during session 2 to help the provider understand the participant's beliefs and practices. R/S can be integrated into any of the skills learned during the intervention (e.g., deep breathing, self-statements, sleep management) or omitted entirely.
Participants in the ECC condition will receive brief biweekly check in calls to provide information about community resources (including mental health), offer emotional support, and assess symptom severity and need for crisis intervention. Emergency procedures will be followed in crisis situations. After 3 months of ECC is completed, participants in the ECC group will be offered the CL intervention.
Outcome measures will be administered for participants in both groups at baseline, 1 month, and 3 months. Participants in ECC will complete measures at 6 months after completion of CL.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- Houston Center for Quality of Care and Utilization Studies
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 50 and older
- Principal or Co-principal diagnosis of GAD or ADNOS
- Must speak English
- Must have a health care or social service provider and provide written authorization to research team to communicate with their health-care or social service provider
- Must live, work, worship, attend community functions, and/or receive health care in target geographic areas
Exclusion Criteria:
- Active suicidal intent
- Current psychosis
- Mania or substance abuse within the last month
- Cognitive impairment according to a Mini Cog screener score of 3 or lower
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CBT
|
6-12 sessions of CBT in person or over the phone
Other Names:
|
|
Active Comparator: Enhanced Community Care (ECC)
|
6 biweekly sessions of ECC over the telephone
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Geriatric Anxiety Inventory
Time Frame: 3 months
|
3 months
|
|
Penn State Worry Questionnaire (PSWQ-A)
Time Frame: 3 months
|
3 months
|
|
Generalized Anxiety Disorder-7
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire-9
Time Frame: 3 months
|
3 months
|
|
|
Insomnia Severity Index
Time Frame: 3 months
|
3 months
|
|
|
Late-Life Functional Disability Index
Time Frame: 3 months
|
3 months
|
|
|
SF-12 Health Survey
Time Frame: 3 months
|
3 months
|
|
|
Client Satisfaction Questionnaire
Time Frame: 3 months
|
3 months
|
|
|
Brief RCOPE
Time Frame: 3 months
|
Religious coping
|
3 months
|
|
Health services use
Time Frame: 3 months
|
3 months
|
|
|
Use of psychotropic medication
Time Frame: 3 months
|
3 months
|
|
|
Brief Multidimensional Measure of Religiousness and Spirituality
Time Frame: 3 months
|
3 months
|
|
|
Satisfaction with Life Scale
Time Frame: 3 months
|
3 months
|
|
|
Geriatric Depression Scale
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Melinda A Stanley, PhD, Baylor College of Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H30928
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Generalized Anxiety Disorder
-
University of Southern CaliforniaNational Institute of Mental Health (NIMH)RecruitingGeneralized Anxiety Disorder (GAD)United States
-
Florida State UniversityRecruitingAnxiety | Generalized Anxiety Disorder (GAD) | WorryingUnited States
-
Wayne State UniversityNational Institute of Mental Health (NIMH)RecruitingAnxiety Disorders | Generalized Anxiety Disorder (GAD)United States
-
AbbVieRecruitingGeneralized Anxiety Disorder (GAD)United States, Puerto Rico
-
Texas Tech UniversityRecruitingGrief | Anxiety Disorder Generalized | Depression in AdultsUnited States
-
University of California, IrvineNational Center for Complementary and Integrative Health (NCCIH)Not yet recruitingMajor Depressive Disorder | Generalized Anxiety Disorder (GAD)
-
PsyScaleNot yet recruitingMajor Depressive Disorder (MDD) | Generalized Anxiety Disorder (GAD)
-
National Health Research Institutes, TaiwanNot yet recruitingMajor Depressive Disorder (MDD) | Generalized Anxiety Disorder (GAD)
-
Psicofarma, S.A. De C.V.Recruiting
-
Bout Me HealingCompletedSubstance Use Disorder (SUD) | Anxiety Disorder GeneralizedUnited States
Clinical Trials on CBT
-
National Institute of Diabetes and Digestive and...Completed
-
VA Office of Research and DevelopmentCorporal Michael J. Crescenz VA Medical CenterCompleted
-
Bogazici UniversityRecruitingAnxietyTurkey (Türkiye)
-
Dr. Nazanin AlaviOnline PsychoTherapy ClinicCompletedMajor Depressive DisorderCanada
-
Psychiatric Research Unit, Region Zealand, DenmarkAarhus University Hospital; University of Copenhagen; Mental Health Centre CopenhagenCompletedPanic Disorder | Depression, Unipolar | Anxiety Disorder SocialDenmark
-
Maastricht UniversitySWOL Limburgs Fonds voor Revalidatie; Flemish Government, Belgium; The Netherlands... and other collaboratorsCompletedTinnitus, Subjective
-
Medical University of South CarolinaCompletedPost Traumatic Stress DisorderUnited States
-
NMP Medical Research InstituteWarwick Research ServicesCompletedDomestic Violence | Emotional Abuse | Mental Abuse of AdultIndia
-
Toronto Rehabilitation InstituteUnknownSpinal Cord InjuriesCanada
-
University of WashingtonNational Multiple Sclerosis SocietyCompleted